abstract |
The invention relates to compounds of formula (I) wherein D, R1, R2, R3 and R4 are defined as in claim 1. The compounds according to the invention are tyrosine kinase inhibitors, especially Met kinase inhibitors and can be used, inter alia, to treat tumors. |